Dose-banding of cytotoxic drugs: A new concept in cancer chemotherapy

American Journal of Health-System Pharmacy

Volumn 58, Issue 18, 2001, Pages 1760-1764

  Plumridge, R J ^a   Sewell, G J ^a  

^a Fremantle Hospital and Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINATE CALCIUM; METHOTREXATE;

BODY SURFACE; CANCER; CANCER CHEMOTHERAPY; CYTOTOXICITY; DOSE CALCULATION; HUMAN; MEDICAL EDUCATION; NOTE; PRIORITY JOURNAL; QUALITY CONTROL; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED KINGDOM;

EID: 0035884435     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.18.1760     Document Type: Note

References (10)

1. Normalisation of anti-cancer drug dosage using body weight and surface area: Is it worthwhile?
2. Body-surface area as a basis for dosing of anticancer agents: Science, myth, or habit
3. Pharmacist develops dose-banding system
4. Rationalisation of chemotherapy services in the University Hospital Birmingham National Health Science Trust
5. Individual dose adaptation of anticancer drugs
6. Estimating the surface area of the human body
7. Body surface area dosing of cytotoxic drugs: Part 1. Its basis, rationale and predictive accuracy of the formulae
8. Stability of three cytotoxic drug infusions in the Graseby 9000 ambulatory infusion pump
9. Current issues in centralised intravenous additive services